Literature DB >> 23739328

HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration.

Arik Cooper1, Mayra García, Constantinos Petrovas, Takuya Yamamoto, Richard A Koup, Gary J Nabel.   

Abstract

Human immunodeficiency virus-1 (HIV-1) has infected more than 60 million people and caused nearly 30 million deaths worldwide, ultimately the consequence of cytolytic infection of CD4(+) T cells. In humans and in macaque models, most of these cells contain viral DNA and are rapidly eliminated at the peak of viraemia, yet the mechanism by which HIV-1 induces helper T-cell death has not been defined. Here we show that virus-induced cell killing is triggered by viral integration. Infection by wild-type HIV-1, but not an integrase-deficient mutant, induced the death of activated primary CD4 lymphocytes. Similarly, raltegravir, a pharmacologic integrase inhibitor, abolished HIV-1-induced cell killing both in cell culture and in CD4(+) T cells from acutely infected subjects. The mechanism of killing during viral integration involved the activation of DNA-dependent protein kinase (DNA-PK), a central integrator of the DNA damage response, which caused phosphorylation of p53 and histone H2AX. Pharmacological inhibition of DNA-PK abolished cell death during HIV-1 infection in vitro, suggesting that processes which reduce DNA-PK activation in CD4 cells could facilitate the formation of latently infected cells that give rise to reservoirs in vivo. We propose that activation of DNA-PK during viral integration has a central role in CD4(+) T-cell depletion, raising the possibility that integrase inhibitors and interventions directed towards DNA-PK may improve T-cell survival and immune function in infected individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739328     DOI: 10.1038/nature12274

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

1.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

2.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

Review 6.  The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?

Authors:  Richard Hill; Patrick W K Lee
Journal:  Cell Cycle       Date:  2010-09-15       Impact factor: 4.534

7.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

8.  Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques.

Authors:  Yoshiaki Nishimura; Charles R Brown; Joseph J Mattapallil; Tatsuhiko Igarashi; Alicia Buckler-White; Bernard A P Lafont; Vanessa M Hirsch; Mario Roederer; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

9.  Derivation of a biologically contained replication system for human immunodeficiency virus type 1.

Authors:  H Chen; T J Boyle; M H Malim; B R Cullen; H K Lyerly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  117 in total

1.  Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells.

Authors:  Sergey Iordanskiy; Fatah Kashanchi
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

2.  HIV: Integration triggers death.

Authors:  Anna Marie Skalka
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

3.  Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.

Authors:  Feng Rao; Jiyoung Cha; Jing Xu; Risheng Xu; M Scott Vandiver; Richa Tyagi; Robert Tokhunts; Michael A Koldobskiy; Chenglai Fu; Roxanne Barrow; Mingxuan Wu; Dorothea Fiedler; James C Barrow; Solomon H Snyder
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

4.  APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.

Authors:  Roni Nowarski; Ponnandy Prabhu; Edan Kenig; Yoav Smith; Elena Britan-Rosich; Moshe Kotler
Journal:  J Mol Biol       Date:  2014-05-21       Impact factor: 5.469

5.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 6.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

Review 7.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

Review 8.  How ISG15 combats viral infection.

Authors:  Brendan T Freitas; Florine E M Scholte; Éric Bergeron; Scott D Pegan
Journal:  Virus Res       Date:  2020-05-31       Impact factor: 3.303

Review 9.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

10.  Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Authors:  Laurelle Jackson; Jessica Hunter; Sandile Cele; Isabella Markham Ferreira; Andrew C Young; Farina Karim; Rajhmun Madansein; Kaylesh J Dullabh; Chih-Yuan Chen; Noel J Buckels; Yashica Ganga; Khadija Khan; Mikael Boulle; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.